On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor antibody screen on the Ortho Clinical Diagnostics VISION Analyzer. This instrumentation change was necessary as Ortho Clinical Diagnostics will be discontinuing support of the existing ProVue instrumentation in the future.
We will notify you of the transition date of our other four laboratories. To read more about this change, click here: Communications
CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...
In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization